Literature DB >> 28296625

A Social Work Response to the Affordable Care Act: Prevention and Early Intervention.

Matthew J Corrigan1, Kathryn Krase2, John Charles Reed3.   

Abstract

The Patient Protection and Affordable Care Act represents a reinvestment in primary care, with a focus on prevention of illness and remediation of the impacts of chronic diseases through a behavioral health framework. Licensed social work professionals, specifically those trained in behavioral health, are a natural fit to help implement these new approaches. Though there are many evidence-based interventions that will be helpful, two that come from the field of substance abuse ought to be specifically beneficial: SAMHSA's SBIRT Model and Motivational Interviewing, developed by Miller and Rollnick. In response to the growing need for specially trained social work practitioners, the Social Work Program at Seton Hall University has developed the initial concentration of its MSW Program around these learning needs.

Entities:  

Keywords:  Affordable Care Act; behavioral health; healthcare reform; social work curriculum

Mesh:

Year:  2017        PMID: 28296625     DOI: 10.1080/02791072.2017.1295333

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  3 in total

1.  Inequities in the delivery of mental health care: a grounded theory study of the policy context of primary care.

Authors:  Rachelle Ashcroft; Matthew Menear; Jose Silveira; Simone Dahrouge; Monica Emode; Jocelyn Booton; Kwame McKenzie
Journal:  Int J Equity Health       Date:  2021-06-19

Review 2.  Social work's scope of practice in the provision of primary mental health care: protocol for a scoping review.

Authors:  Rachelle Ashcroft; Toula Kourgiantakis; Judith Belle Brown
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

3.  The Role of Social Workers in Interprofessional Primary Healthcare Teams.

Authors:  Vela Tadic; Rachelle Ashcroft; Judith Belle Brown; Simone Dahrouge
Journal:  Healthc Policy       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.